Advanced in Ovarian Cancer

Dr. Branimir I. Sikic

Hematology Oncology
300 Pasteur Dr, 
Stanford, CA 
Advanced in Ovarian Cancer
300 Pasteur Dr, 
Stanford, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Branimir Sikic is a Hematologist Oncology provider in Stanford, California. Dr. Sikic is rated as an Advanced provider by MediFind in the treatment of Ovarian Cancer. His top areas of expertise are Ovarian Cancer, Breast Cancer, Acute Erythroid Leukemia (AEL), and Acute Myeloid Leukemia (AML).

His clinical research consists of co-authoring 30 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of Ovarian Cancer.

Specialties
Hematology Oncology
Licenses
Internal Medicine in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

300 Pasteur Dr, Stanford, CA 94305

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase l/ll Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of Anti-CD27 Antibody (Varlilumab) Administered in Combination With Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
A Phase l/ll Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of Anti-CD27 Antibody (Varlilumab) Administered in Combination With Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors
Enrollment Status: Completed
Publish Date: December 09, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgical Resection for Locally-Advanced Rectal Cancer
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgical Resection for Locally-Advanced Rectal Cancer
Enrollment Status: Terminated
Publish Date: December 08, 2017
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

30 Total Publications

Editorial Expression of Concern: Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition.
Editorial Expression of Concern: Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition.
Journal: British journal of cancer
Published: October 06, 2025
Similar Doctors
Elite in Ovarian Cancer
Dr. Michael A. Bookman
Oncology | Hematology Oncology
Elite in Ovarian Cancer
Dr. Michael A. Bookman
Oncology | Hematology Oncology

San Francisco Medical Center

2238 Geary Blvd, 2nd Floor, 
San Francisco, CA 
 (28.2 miles away)
415-833-3692
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Bookman is a Hematologist Oncology specialist and an Oncologist in San Francisco, California. Dr. Bookman is rated as a Distinguished provider by MediFind in the treatment of Ovarian Cancer. His top areas of expertise are Ovarian Cancer, Vaginal Cancer, Testicular Yolk Sac Tumor, and Ovarian Carcinosarcoma. Dr. Bookman is currently accepting new patients.

Allison W. Kurian
Distinguished in Ovarian Cancer
Dr. Allison W. Kurian
Oncology | Hematology Oncology | Hematology
Distinguished in Ovarian Cancer
Dr. Allison W. Kurian
Oncology | Hematology Oncology | Hematology

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
 (0.1 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Allison Kurian is an Oncologist and a Hematologist Oncology provider in Stanford, California. Dr. Kurian is rated as an Elite provider by MediFind in the treatment of Ovarian Cancer. Her top areas of expertise are Breast Cancer, Ovarian Cancer, Inflammatory Breast Cancer, Li-Fraumeni Syndrome, and Salpingo-Oophorectomy.

Distinguished in Ovarian Cancer
Dr. Lesley C. Martin
Hematology Oncology | Hematology | Oncology
Distinguished in Ovarian Cancer
Dr. Lesley C. Martin
Hematology Oncology | Hematology | Oncology

John Muir Physician Network

2571 Park Ave, 
Concord, CA 
 (38.9 miles away)
925-674-2100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Lesley Martin is a Hematologist Oncology specialist and a Hematologist in Concord, California. Dr. Martin is rated as a Distinguished provider by MediFind in the treatment of Ovarian Cancer. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Lung Cancer.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sikic's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile